Thromboembolism as the adverse event of combined oral contraceptives in Japan

Thrombosis Research

Volumn 136, Issue 6, 2015, Pages 1110-1115

  Sugiura, Kazuko ^a,c   Kobayashi, Takao ^b   Ojima, Toshiyuki ^c  

^a NAGOYA CITY UNIVERSITY   (Japan)

^b HAMAMATSU MEDICAL CENTER   (Japan)

^c HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Arterial embolism and thrombosis; Combined oral contraceptives; Progestin; Venous thromboembolism

Indexed keywords

DESOGESTREL PLUS ETHINYLESTRADIOL; DIENOGEST; DROSPIRENONE PLUS ETHINYLESTRADIOL; ETHINYLESTRADIOL PLUS LEVONORGESTREL; ETHINYLESTRADIOL PLUS NORETHISTERONE; ETHINYLESTRADIOL PLUS NORGESTREL; LEVONORGESTREL; MESTRANOL PLUS NORETHISTERONE; NORETHISTERONE; ORAL CONTRACEPTIVE AGENT;

ANEMIA; ARTERY EMBOLISM; ARTERY THROMBOSIS; ARTICLE; BLEEDING DISORDER; BRAIN INFARCTION; CAROTID ARTERY THROMBOSIS; DEEP VEIN THROMBOSIS; FEMALE; HEART ATRIUM THROMBOSIS; HUMAN; INCIDENCE; INFERIOR CAVA VEIN THROMBOSIS; ISCHEMIC HEART DISEASE; JAPAN; JUGULAR VEIN THROMBOSIS; KIDNEY ARTERY EMBOLISM; KIDNEY VEIN THROMBOSIS; LEG THROMBOSIS; LEVONORGESTREL RELEASING INTRAUTERINE SYSTEM; LIVER VEIN THROMBOSIS; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MESENTERIC ARTERY THROMBOSIS; NAUSEA; OCCLUSIVE CEREBROVASCULAR DISEASE; PELVIC VEIN THROMBOSIS; PORTAL VEIN THROMBOSIS; PRIORITY JOURNAL; RENAL ARTERY THROMBOSIS; RETINA ARTERY THROMBOSIS; RETINA VEIN THROMBOSIS; SPINAL ARTERY THROMBOSIS; SPLENIC VEIN THROMBOSIS; SUDDEN DEATH; THROMBOEMBOLISM; UPPER EXTREMITY DEEP VEIN THROMBOSIS; VEIN EMBOLISM; VEIN THROMBOSIS; VENOUS THROMBOEMBOLISM; VOMITING; CHEMICALLY INDUCED; TIME FACTOR;

CONTRACEPTIVES, ORAL, COMBINED; FEMALE; HUMANS; INCIDENCE; TIME FACTORS; VENOUS THROMBOEMBOLISM;

EID: 84949221494     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2015.09.011     Document Type: Article

References (28)

1. W.M. Jordan Pulmonary embolism Lancet 278 1961 1146 1147
2. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception Venous thromboembolic disease and combined oral contraceptives: results of international multicentre case-control study Lancet 346 1995 1575 1582
3. World Health Organization Collaborative Study on Cardiovascular Disease and Steroid Hormone Contraception Effect of different progestagens in low oestrogen oral contraceptives on venous thromboembolic disease Lancet 346 1995 1582 1588
4. H. Jick, S.S. Jick, V. Gurewich, M.W. Myers, and C. Vasilakis Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components Lancet 346 1995 1589 1593
5. H. Jick, J.A. Kaye, C. Vasilakis-Scaramozza, and S.S. Jick Risk of venous thromboembolism among users of third generation oral contraceptives compared with users of oral contraceptives with levonorgestrel before and after 1995: cohort and case-control analysis BMJ 321 2000 1190 1195
6. W.O. Spitzer, M.A. Lewis, L.A. Heinemann, M. Thorogood, and K.D. MacRae Third generation oral contraceptives and risk of venous thromboembolic disorders: an international case-control study BMJ 312 1996 83 88
7. R.D. Farmer, R.A. Lawrenson, C.R. Thompson, J.G. Kennedy, and I.R. Hambleton Population-based study of risk of venous thromboembolism associated with various oral contraceptives Lancet 349 1997 83 88
8. O. Lidegaard, B. Edström, and S. Kreiner Oral contraceptives and venous thromboembolism. A five-year national case-control study Contraception 65 2002 187 196
9. O. Lidegaard, L.H. Nielsen, C.W. Skovlund, F.E. Skjeldestad, and E. Løkkegaard Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: Danish cohort study, 2001-9 BMJ 343 Oct 25 2011 d6423 10.1136/bmj.d6423
10. B.H. Stegeman, M. de Bastos, F.R. Rosendaal, A. van Hylckama Vlieg, F.M. Helmerhorst, T. Stijnen, and et al. Different combined oral contraceptives and the risk of venous thrombosis: systematic review and network meta-analysis BMJ 347 Sep 12 2013 f5298 10.1136/bmj.f5298
11. Y. Vinogradova, C. Coupland, and J. Hippisley-Cox Use of combined oral contraceptives and risk of venous thromboembolism: nested case-control studies using the QResearch and the CPRD databases BMJ 350 May 26 2015 h2135 10.1136/bmj.h2135
12. J. Conard Biological coagulation findings in third-generation oral contraceptives Hum. Reprod. Update 5 1999 672 680
13. E.M. Bladbjerg, S.O. Skouby, L.F. Andersen, and J. Jespersen Effects of different progestin regimens in hormone replacement therapy on blood coagulation factor VII and tissue factor pathway inhibitor Hum. Reprod. 17 2002 3235 3241
14. A. Suzuki, N. Sanda, Y. Miyawaki, Y. Fujimori, T. Yamada, A. Takagi, and et al. Down-regulation of PROS1 gene expression by 17beta-estradiol via estrogen receptor alpha (ERalpha)-Sp1 interaction recruiting receptor-interacting protein 140 and the corepressor-HDAC3 complex J. Biol. Chem. 285 2010 13444 13453
15. H.O. Ali, B. Stavik, E. Dørum, N. Iversen, P.M. Sandset, and G. Skretting Oestrogen induced downregulation of TFPI expression is mediated by ERα Thromb. Res. 134 2014 138 143
16. Q. Hughes, M. Watson, V. Cole, M. Sayer, R. Baker, and J. Staton Upregulation of protein S by progestins J. Thromb. Haemost. 5 2007 2243 2249
17. T. Adachi, and S. Sakamoto Thromboembolism during hormone therapy in Japanese women Semin. Thromb. Hemost. 31 2005 272 280
18. N. Maitra, R. Kulier, K.W. Bloemenkamp, F.M. Helmerhorst, and A.M. Gülmezoglu Progestogens in combined oral contraceptives for contraception Cochrane Database Syst. Rev. 3 2004 CD004861
19. FDA Drug Safety Communication Updated information about the risk of blood clots in women taking birth control pills containing drospirenone http://www.fda.gov/Drugs/DrugSafety/ucm299305.htm 04.10.2012
20. S. Mantha, R. Karp, V. Raghavan, N. Terrin, K.A. Bauer, and J.I. Zwicker Assessing the risk of venous thromboembolic events in women taking progestin-only contraception: a meta-analysis BMJ 345 Aug 7 2012 e4944 10.1136/bmj.e4944
21. C. Vasilakis-Scaramozza, and H. Jick Risk of venous thromboembolism with cyproterone or levonorgestrel contraceptives Lancet 358 2001 1427 1429
22. J. Dinger, K. Bardenheuer, and K. Heinemann Cardiovascular and general safety of a 24-day regimen of drospirenone-containing combined oral contraceptives: final results from the international active surveillance study of women taking oral contraceptives Contraception 89 2014 253 263
23. O. Lidegaard, E. Løkkegaard, A. Jensen, C.W. Skovlund, and N. Keiding Thrombotic stroke and myocardial infarction with hormonal contraception N. Engl. J. Med. 366 2012 2257 2266
24. M. Nakamura, T. Miyata, Y. Ozeki, M. Takayama, K. Komori, N. Yamada, and et al. Current venous thromboembolism management and outcomes in Japan Circ. J. 78 2014 708 717
25. M. Sakuma, K. Sugimura, M. Nakamura, T. Takahashi, O. Kitamurai, T. Yazu, and et al. Unusual pulmonary embolism-septic pulmonary embolism and amniotic fluid embolism- Circ. J. 71 2007 772 775
26. M. Sakuma, M. Nakamura, T. Takahashi, O. Kitamurai, T. Yazu, N. Yamada, and et al. Pulmonary embolism is an important cause of death in young adults Circ. J. 71 2007 1765 1770
27. T. Kobayashi, M. Nakabayashi, M. Ishikawa, T. Adachi, G. Kobashi, M. Maeda, and et al. Pulmonary thromboembolism in obstetrics and gynecology increased by 6.5 fold over the last decade in Japan Circ. J. 72 2008 753 756
28. M. Sakuma, M. Nakamura, N. Yamada, S. Ota, K. Shirato, T. Nakano, and et al. Venous thromboembolism-deep vein thrombosis with pulmonary embolism, deep vein thrombosis alone, pulmonary embolism alone- Circ. J. 73 2009 305 309